世界の神経学臨床試験市場規模は2028年までに74億米ドルに達する見込みです。同市場は、2021年から2028年にかけて、5.5%のCAGRで拡大すると予測されています。これは、大手製薬会社が神経学分野で革新的な試験を実施していること、国立神経疾患・脳卒中研究所（NINDS）からの政府助成金が増加していること、臨床試験に関する規制要件が厳しくなっていることなどが主な要因です。
神経科学は、引き続き健全なレベルの初期投資を受けています。2018年には、癌に次いで15億米ドルのベンチャーキャピタルからの資金提供を受けており、投資家が近い将来、製薬会社の大型買収が功を奏することを期待していることを示しています。近年の多くの後期臨床失敗を乗り越えようと努力している業界では、病気の早期診断が、痛みやアルツハイマー病を中心とした複雑な神経科学分野への投資を呼び、取引を促進しています。
取引量の面では、腫瘍に匹敵する治療分野はありませんが、神経科学は最も近い競合分野の一つとなっています。2017年には予想総額が減少したものの、神経科学関連のライセンス契約数は過去10年間で徐々に増加しています。神経科学分野の契約の大部分（90％）は、主に神経学に焦点を当てており、これは2つの分野の研究開発活動のレベルに対応しています。
実験的な治療薬の多くは、現場での投与と慎重に計画された結果指標の評価を必要とするため、COVID-19の大流行は、安全性と有効性の証明に必要な正確な手順の実施に大きな支障をきたしました。COVID-19により、脳卒中の臨床試験を行う施設のネットワークが停止しました。その後、現地の状況や規制当局の監督を考慮して、段階的に研究を再開する計画が立てられました。このアプローチにより、55日以内に、1つを除くすべての進行中の研究において、ある程度の研究活動を再開することに成功しました。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1: Understanding market dynamics
1.8.2 Objective - 2: Understanding market estimates and forecasts
1.8.3 Objective - 3: Understanding attributes such as strategy framework and competitor categorization
1.8.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Neurology Clinical Trials Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing neurological disease, such as dementia, stroke, and peripheral neuropathy
3.2.1.2 Increasing R&D investments
3.2.1.3 Stringent Regulatory Requirements
3.2.2 Market Restraint Analysis
3.2.2.1 High Failure Rates of Trials
3.2.2.2 Rising Cost of Clinical Trials
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Neurology Clinical Trials: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
Chapter 4 Neurology Clinical Trials Market: Phase Segment Analysis
4.1 Neurology Clinical Trials Market: Phase Market Share Analysis, 2020 & 2028
4.2 Phase I
4.2.1 Phase I Market, 2016 - 2028 (USD Million)
4.3 Phase II
4.3.1 Phase II Market, 2016 - 2028 (USD Million)
4.4 Phase III
4.4.1 Phase III Market, 2016 - 2028 (USD Million)
4.5 Phase IV
4.5.1 Phase IV Market, 2016 - 2028 (USD Million)
Chapter 5 Neurology Clinical Trials Market: Study Design Segment Analysis
5.1 Neurology Clinical Trials Market: Study Design Market Share Analysis, 2020 & 2028
5.2 Interventional
5.2.1 Interventional Market, 2016 - 2028 (USD Million)
5.3 Observational
5.3.1 Observational Market, 2016 - 2028 (USD Million)
5.4 Expanded Access
5.4.1 Expanded Access Market, 2016 - 2028 (USD Million)
Chapter 6 Neurology Clinical Trials Market: Indication Segment Analysis
6.1 Neurology Clinical Trials: Indication Market Share Analysis, 2020 & 2028
6.2 Epilepsy
6.2.1 Epilepsy Market, 2016 - 2028 (USD Million)
6.3 Parkinson's Disease
6.3.1 Parkinson's Disease Market, 2016 - 2028 (USD Million)
6.4 Huntington's Disease
6.4.1 Huntington's Disease Market, 2016 - 2028 (USD Million)
6.5 Stroke
6.5.1 Stroke Market, 2016 - 2028 (USD Million)
6.6 Traumatic Brain Injury
6.6.1 Traumatic Brain Injury Market, 2016 - 2028 (USD Million)
6.7 Amyotrophic Lateral Sclerosis
6.7.1 Amyotrophic Lateral Sclerosis Market, 2016 - 2028 (USD Million)
6.8 Muscle regeneration
6.8.1 Muscle regeneration Market, 2016 - 2028 (USD Million)
6.9 Others
6.9.1 Others Market, 2016 - 2028 (USD Million)
Chapter 7 Neurology Clinical Trials Market: Regional Analysis
7.1 Neurology Clinical Trials Market: Regional Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Europe Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.4 France
7.3.4.1 France Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.3 China
7.4.3.1 China Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 India Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.5 Australia
7.4.5.1Australia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 MEA Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 IQVIA
8.1.1 Company Overview
8.1.2 Service Benchmarking
8.1.3 Financial Performance
8.1.4 Strategic Initiatives
8.2 Novartis
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Service Benchmarking
8.2.4 Strategic Initiatives
8.3 Covance
8.3.1 Company Overview
8.3.2 Service Benchmarking
8.3.3 Strategic Initiatives
8.4 Medpace
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Service Benchmarking
8.5 Charles River Laboratories
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Service Benchmarking
8.6 Icon Plc
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Service Benchmarking
8.7 GlaxoSmithKline
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Service Benchmarking
8.7.4 Strategic Initiatives
8.8 Aurora healthcare
8.8.1 Company Overview
8.8.2 Financial Performance
8.8.3 Service Benchmarking
8.9 Charles River Laboratories
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Service Benchmarking
8.9.4 Strategic Initiatives
8.10 Biogen
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Service Benchmarking
8.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Neurology Clinical Trials Market, by region, 2016 - 2028 (USD Million)
Table 4 Global Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 5 Global Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 6 Global Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 7 North America Neurology Clinical Trials Market, by Country, 2016 - 2028 (USD Million)
Table 8 North America Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 9 North America Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 10 North America Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 11 U.S. Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 12 U.S. Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 13 U.S. Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 14 Canada Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 15 Canada Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 16 Canada Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 17 Europe Neurology Clinical Trials Market, by Country, 2016 - 2028 (USD Million)
Table 18 Europe Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 19 Europe Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 20 Europe Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 21 U.K. Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 22 U.K. Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 23 U.K. Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 24 Germany Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 25 Germany Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 26 Germany Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 27 France Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 28 France Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 29 France Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 30 Italy Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 31 Italy Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 32 Italy Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 33 Spain Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 34 Spain Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 35 Spain Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 36 Asia Pacific Neurology Clinical Trials Market, by Country, 2016 - 2028 (USD Million)
Table 37 Asia Pacific Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 38 Asia Pacific Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 39 Asia Pacific Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 40 India Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 41 India Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 42 India Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 43 Japan Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 44 Japan Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 45 Japan Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 46 China Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 47 China Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 48 China Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 49 Australia Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 50 Australia Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 51 Australia Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 52 South Korea Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 53 South Korea Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 54 South Korea Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 55 Latin America Neurology Clinical Trials Market, by Country, 2016 - 2028 (USD Million)
Table 56 Latin America Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 57 Latin America Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 58 Latin America Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 59 Brazil Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 60 Brazil Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 61 Brazil Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 62 Mexico Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 63 Mexico Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 64 Mexico Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 65 Argentina Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 66 Argentina Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 67 Argentina Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 68 Colombia Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 69 Colombia Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 70 Colombia Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 71 MEA Neurology Clinical Trials Market, by Country, 2016 - 2028 (USD Million)
Table 72 MEA Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 73 MEA Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 74 MEA Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 75 South Africa Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 76 South Africa Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 77 South Africa Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 78 South Arabia Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 79 South Arabia Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 80 South Arabia Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
Table 81 UAE Neurology Clinical Trials Market, by Phase, 2016 - 2028 (USD Million)
Table 82 UAE Neurology Clinical Trials Market, by Study Design, 2016 - 2028 (USD Million)
Table 83 UAE Neurology Clinical Trials Market, by Indication, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Neurology clinical trials market snapshot (2020)
Fig. 8 Neurology clinical trials market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Porter’s five forces analysis
Fig. 13 PESTEL analysis
Fig. 14 Neurology clinical trials market phase outlook: Segment dashboard
Fig. 15 Neurology clinical trials market: Phase movement analysis
Fig. 16 Phase I market, 2016 - 2028 (USD Million)
Fig. 17 Phase II market, 2016 - 2028 (USD Million)
Fig. 18 Phase III market, 2016 - 2028 (USD Million)
Fig. 19 Phase IV market, 2016 - 2028 (USD Million)
Fig. 20 Neurology clinical trials market study design outlook: Segment dashboard
Fig. 21 Neurology clinical trials market: Study Design movement analysis
Fig. 22 Interventional market, 2016 - 2028 (USD Million)
Fig. 23 Observational market, 2016 - 2028 (USD Million)
Fig. 24 Expanded access market, 2016 - 2028 (USD Million)
Fig. 25 Neurology clinical trials market indication outlook: Segment dashboard
Fig. 26 Neurology clinical trials market: Indication movement analysis
Fig. 27 Epilepsy market, 2016 - 2028 (USD Million)
Fig. 28 Parkinson's disease market, 2016 - 2028 (USD Million)
Fig. 29 Huntington's disease market, 2016 - 2028 (USD Million)
Fig. 30 Stroke indication market, 2016 - 2028 (USD Million)
Fig. 31 Traumatic Brain Injury market, 2016 - 2028 (USD Million)
Fig. 32 Amyotrophic Lateral Sclerosis market, 2016 - 2028 (USD Million)
Fig. 33 Muscle regeneration market, 2016 - 2028 (USD Million)
Fig. 34 Others indication market, 2016 - 2028 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2020 & 2028
Fig. 37 North America market, 2016 - 2028 (USD Million)
Fig. 38 U.S. market, 2016 - 2028 (USD Million)
Fig. 39 Canada market, 2016 - 2028 (USD Million)
Fig. 40 Europe market, 2016 - 2028 (USD Million)
Fig. 41 U.K. market, 2016 - 2028 (USD Million)
Fig. 42 Germany market, 2016 - 2028 (USD Million)
Fig. 43 France market, 2016 - 2028 (USD Million)
Fig. 44 Italy market, 2016 - 2028 (USD Million)
Fig. 45 Spain market, 2016 - 2028 (USD Million)
Fig. 46 Asia Pacific market, 2016 - 2028 (USD Million)
Fig. 47 Japan market, 2016 - 2028 (USD Million)
Fig. 48 China market, 2016 - 2028 (USD Million)
Fig. 49 India market, 2016 - 2028 (USD Million)
Fig. 50 Australia market, 2016 - 2028 (USD Million)
Fig. 51 South Korea market, 2016 - 2028 (USD Million)
Fig. 52 Latin America market, 2016 - 2028 (USD Million)
Fig. 53 Brazil market, 2016 - 2028 (USD Million)
Fig. 54 Mexico market, 2016 - 2028 (USD Million)
Fig. 55 Argentina market, 2016 - 2028 (USD Million)
Fig. 56 Colombia market, 2016 - 2028 (USD Million)
Fig. 57 MEA market, 2016 - 2028 (USD Million)
Fig. 58 South Africa market, 2016 - 2028 (USD Million
Fig. 59 Saudi Arabia market, 2016 - 2028 (USD Million)
Fig. 60 UAE market, 2016 - 2028 (USD Million)
